Free radicals generated during peroxidase-catalyzed oxidation of two xenobiotics, carcinogenic Sudan I and an anticancer agent ellipticine, easily attack unmodified proteins but not glycoproteins. A significant inverse correlation between the extent of glycosylation of proteins and the degree of binding of Sudan I or ellipticine radicals to these proteins was observed, whereby the protection only occurs if oligosaccharides are covalently bound to the proteins. No influence of any other variables was found and further confirmed by experiments with proteins containing identical polypeptide chains differing only by the absence (ribonuclease A) or the presence (ribonuclease B) of a single oligosaccharide. The free radicals that are subject of this study did not react with the oligosaccharides because higher levels of the corresponding dimers, reaction products of the radicals, were found in presence of highly glycosylated proteins. The results indicate that carbohydrates protect polypeptides against modification by free radicals derived from toxic xenobiotics and provide passive shielding of the protein moiety.
Peroxidases are enzymes that are known to oxidize a wide variety of organic hydrogen donors including xenobiotics such as toxicants, carcinogens, and drugs to free radicals, which easily bind to DNA and numerous proteins, thereby frequently destroying their biological function (Díaz-Gomez et al., 2008; Johansson et al., 2008; Kaplowitz et al., 1986; Liebler, 2008; Nelson, 1995; Niemelä, 2001; Salomon et al., 2000; Williams and Phillips, 2000; Zenser et al., 2002) . We have found that such free radicals are also generated from a carcinogenic azo dye Sudan I and an antitumor alkaloid ellipticine studied in our laboratory ( Fig. 1) (Dračínský et al., 2009; Stiborová et al., 1990 Stiborová et al., , 1996 Stiborová et al., , 2007 . These free radicals depending on the environment in which they exist (1) form additional metabolites (Dračínský et al., 2009; Stiborová et al., 1996 Stiborová et al., , 2007 , (2) react with NADH or ascorbate (Stiborová et al., 1990 (Stiborová et al., , 1996 (Stiborová et al., , 2007 , (3) react with SH groups of glutathione (reducing Sudan I or ellipticine radicals with the formation of a thiyl radical) (Stiborová et al., 1990 (Stiborová et al., , 2007 , and (4) react with themselves or after further oxidation with nucleophilic compounds such as DNA (Dračínský et al., 2009; Stiborová et al., 1990 Stiborová et al., , 1996 Stiborová et al., , 2007 and proteins (Fig. 1) to form potentially toxic adducts in vitro and in vivo. DNA adducts generated by carcinogens including Sudan I are considered to be critically involved in the molecular mechanism of carcinogenesis (Hecht, 2008; Phillips, 2002; Stiborová et al., 1999 Stiborová et al., , 2002a Stiborová et al., , 2006 Turesky, 2002) . DNA adducts generated by ellipticine appear to be responsible for its pharmacological and genotoxic properties (Frei et al., 2002; Stiborová et al., 2001a Stiborová et al., , 2003 Stiborová et al., , 2004 Stiborová et al., , 2007 . The attack of proteins by free radicals generated in living cells both by endogenous and exogenous compounds is critical for protein aging and modulation of other biological properties of the protein molecule (Lesser, 2006) . Surprisingly, our earlier experiments showed that even though Sudan I and ellipticine oxidized by horseradish peroxidase (HRP) easily formed adducts with microsomal proteins from liver or ram seminal vesicles as well as serum albumin, very little reaction occurred with the peroxidase itself (Stiborová et al., 1990) . One would assume that during the HRP-mediated oxidation of its substrates, adducts with the enzyme itself should ensue, maybe even resulting in enzyme inactivation. We, however, did not observe a decrease in enzyme activity during the oxidation of Sudan I, ellipticine, or other substrates, such as o-anisidine (Stiborová et al., 2002b) , N-nitrosomethylaniline (Stiborová et al., 1992) , and aristolochic acid I (Stiborová et al., 2001b) .
Because isoenzyme C of HRP used in our experiments is highly glycosylated (neutral and amino sugars account for 30% of the weight of the enzyme) (Gray et al., 1998; Shannon et al., 1966; Welinder, 1979) , a hypothesis has been suggested that its carbohydrate moieties may shield against the attack of the free radicals or other reactive eletrophilic species generated during oxidation of its substrates, thereby protecting the enzyme in vitro and in vivo. Such a hypothesis is supported by data from Silva et al. (1990) , who reported that when the HRP protein molecule was 70% deglycosylated, its enzymatic activity with isobutyraldehyde or the trimethylsilyl enol ether as substrates was reduced. Concomitantly, the initially active deglycosylated enzyme becomes inactivated during the course of the reaction (Silva et al., 1990) . Likewise, recombinant HRP (isoenzyme C) prepared in Escherichia coli as a nonglycosylated polypeptide was easily inactivated during the reactions it catalyzed (Mareeva et al., 1996) . Deglycosylation of another glycoprotein enzyme, thyroid peroxidase, also led to a decrease in its enzymatic activity (Giraud et al., 1992) . However, the questions whether the inactivation of these enzymes is a consequence of the binding of products to the deglycosylated enzyme, and whether this feature is of general importance, valid also for other glycoproteins, remain to be answered.
In order to address these questions, we investigated the effect of carbohydrate chains on the binding of free radicals to glycoproteins. One-electron oxidations by HRP of Sudan I and ellipticine to free radicals (Dračínský et al., 2009; Stiborová et al., 1990 Stiborová et al., , 1996 Stiborová et al., , 2007 were employed as model reactions for this study. Here, we present for the first time the data that carbohydrate moieties in glycoproteins can protect their polypeptide chains against the attack of free radicals and suggest this property to be a novel role of oligosaccharide chains in glycoproteins.
MATERIALS AND METHODS
Materials. Chemicals were obtained from the following sources: Sudan I (>99% based on high-performance liquid chromatography [HPLC] ) from British Drug Houses, Poole, UK; N-glycanase F (PNGaseF); and endoglycosidase H (EndoH f ) was a recombinant fusion protein of endoH and maltosebinding protein from New England BioLabs, Ipswich, MA; glutathione (reduced) from Roche Mannheim, Germany; ellipticine, HRP (isoenzyme C having specific activity of 300 purpurogallin units/mg protein), and NADH from Sigma Chemical Co. (St Louis, MO); and hydrogen peroxide and L-ascorbic acid from Merck (Darmstadt, Germany). All these and other chemicals were of analytical purity or better. The 3 H-labeled ellipticine (24.6 GBq/mmol) was prepared by a catalytic exchange method with 3 H gas and stored in methanol at À18°C (Stiborová et al., 2001a) . Radiochemical purity of the compounds was >98% (thin layer chromatography). The individual proteins and (glyco)proteins were obtained from commercial sources. Human serum albumin (HSA), bovine serum albumin (BSA), ovalbumin, fetuin, glucoamylase, ovomucoid, ribonuclease A, ribonuclease B, and a 1 -acid glycoprotein were from Sigma. Tamm-Horsfall glycoprotein was purified as described (Serafini-Cessi et al., 1984) . The (glyco)proteins were extensively purified to homogeneity when required according to the published protocols (Bezouška et al., 1999) . Ribonuclease A was separated from ribonuclease B on immobilized Concanavalin A (Rudd et al., 1994) .
Incubations. The incubation mixtures for the oxidation of Sudan I contained the following in a final volume of 0.5 ml: 50mM sodium phosphate buffer (pH 8.4), 100lM Sudan I dissolved in 5 ll methanol, 0.5lM HRP, which corresponds to activity of 0.286 lmol purpurogallin formed per minute, and 500lM hydrogen peroxide. Reactions were initiated by adding Sudan I. Control incubations were either without HRP, or without hydrogen peroxide, or without Sudan I. After incubation (37°C, 30 min), the mixtures were extracted with ethyl acetate (2 3 1 ml). The extracts were evaporated and dissolved in 50 ll of methanol. Sudan I and its oxidation product were separated by reverse-phase HPLC (MN Nucleosil 100-5 C18) using isocratic elution by 90% methanol in 10% 0.1M NH 4 HCO 3 (pH 8), elution rate was 0.8 ml/min, and detection was at 254 nm. Recoveries of Sudan I metabolites were~95%. The product peak with the retention time (rt) of 7.5 min was collected and analyzed by mass spectrometry (Dračínský et al., 2009) .
The incubation mixtures used to analyze the effect of HSA on Sudan I metabolites were of the same composition, but contained also 0.1-1.5 mg/ml of HSA. The incubations, in which the binding of Sudan I activated with HRP to (glyco)proteins was evaluated, were of the same composition, but contained (glyco)protein equivalent to 1 mg/ml of polypeptide component. Reactions were initiated by adding Sudan I. After incubation (37°C, 30 min), the mixtures were extracted with ethyl acetate (2 3 1 ml), and the extracts were evaporated, dissolved in methanol, and analyzed using the HPLC procedure described above. Proteins (glycoproteins) present in the incubation mixtures were isolated from these mixtures after extraction with ethyl acetate (see above) using acid precipitation in the presence of Triton X-100. Hundred microliters of 10% Triton X-100 was added to the water phase, followed by addition of 200 ll of 75% trichloroacetic acid, and the mixtures were centrifuged at 0°C for 10 min; the precipitates were washed with cold mixture of diethyl ether:ethanol (3:1), cold acetone, and diethyl ether (always twice with 2 ml); and the obtained pellets were dissolved in 1 ml of 2mM NaOH. The levels of Sudan I binding to model (glyco)proteins were determined spectrophotometrically. Absorbance of Sudan I-(glyco)protein adducts was determined at 455 nm against the corresponding control. The control incubations for each (glyco)protein were prepared and treated as described above except that the H 2 O 2 was omitted from the incubation mixture.
Incubation mixtures used to evaluate the oxidation of ellipticine by HRP in a final volume of 500 ll, consisted of 50mM potassium phosphate buffer (pH 7.4), 100lM ellipticine (dissolved in 5 ll methanol), 0.5lM of HRP, and hydrogen peroxide (200lM). Control incubations were either without HRP, or without hydrogen peroxide, or without ellipticine. Incubations were carried out at 37°C for 30 min. Reactions were initiated by adding ellipticine. After incubations, 5 ll of 1mM of salicylamide in methanol was added as an internal standard and ellipticine, and its metabolite were extracted twice with ethyl acetate (2 3 1 ml). The ellipticine metabolites were separated by HPLC. The column used was a 5-lm Ultrasphere ODS (Beckman, 4.6 3 250 mm), preceeded by a C-18 guard column. The eluent was 45-90% methanol in 10mM ammonium acetate (pH 2.8), with flow rate of 0.8 ml/min, and the detection was at 296 nm. Recoveries of ellipticine metabolites were~95%. One product peak with an rt of 19.95 min and ellipticine with rt of 11.85 min were separated by HPLC. The product peak with rt of 19.95 min was collected and analyzed by nuclear magnetic resonance (NMR) (Stiborová et al., 2007) .
The incubation mixtures used to analyze the effect of HSA on ellipticine metabolites contained the following in a final volume of 0.5 ml: 10mM sodium phosphate buffer (pH 7.4), 0.5lM HRP, 0.1-1.0 mg/ml of HSA, 100lM ]ellipticine activated with HRP to (glyco)proteins was evaluated, were of the same composition, but contained (glyco)protein equivalent to 1 mg/ml of polypeptide component. Control incubations were either without peroxidases, or without hydrogen peroxide, or without (glyco)proteins, or without ellipticine. Incubations were carried out at 37°C for 30 min. All reactions were initiated by adding [ 3 H]ellipticine dissolved in methanol (final concentration of methanol was 1%). Proteins (glycoproteins) present in the incubation mixtures were isolated from these mixtures after extraction with ethyl acetate (see above) using acid precipitation in the presence of Triton X-100. Hundred microliters of 10% Triton X-100 was added to the water phase, followed by addition of 200 ll of 75% trichloroacetic acid; the mixtures were centrifuged at 0°C for 10 min; the precipitates were washed with cold mixture of diethyl ether:ethanol (3:1), cold acetone, and diethyl ether (always twice with 2 ml); and the pellets were dissolved in 1 ml of 2mM NaOH. The amount of [ 3 H]ellipticine in the dissolved precipitates was determined in 0.1-ml aliquots in a Packard Tri-Carb 2000 CA scintillation counter after adding 10 ml of Packard Ultra Gold X liquid scintillation cocktail. Binding of [ 3 H]-ellipticine metabolites to protein were calculated from the specific activity of the [ 3 H] ellipticine added to the incubations and related to the total amount of protein.
The effect of L-ascorbic acid, NADH, and glutathione on binding of [ 3 H]ellipticine on HSA was performed by the addition of 0.1 or 0.5mM glutathione, L-ascorbic acid, or NADH dissolved in 50mM phosphate buffer, pH 7.4, to the incubation mixture described above.
Mass spectrometry. Spectra of Sudan I metabolites were measured on Esquire 3000 (Bruker Daltonics) using atmospheric pressure chemical ionization or electrospray ionization (ESI) in positive or negative mode. The mass spectra were internally calibrated using background ions with known elemental composition (Dračínský et al., 2009) . Molecular masses of proteins and glycoproteins were measured by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) on a Bruker Daltonics Biflex III instrument (Bezouška et al., 1999) .
Determination of carbohydrate content. The saccharide content (percentage of the carbohydrates [wt/wt]) of model (glyco)proteins was calculated according to the formula:
where M nat refers to the molecular mass of the dominant species of the native model (glyco)protein determined by MAIDI-TOFMS and M pept is the calculated mass of polypeptide chain of corresponding protein. The resulting value is assigned experimental carbohydrate content. The purely theoretical carbohydrate content value of evaluated (glyco)proteins was calculated as follows:
where M sacch refers to the molecular mass of the most populated saccharide species weighted by the frequency of their occurrence.
NMR spectroscopy.
1 H NMR spectra of the ellipticine dimer were measured on a Varian UNITY Inova 400 MHz instrument (400 MHz for 1 H). The samples were measured in deuterated dimethylsulfoxide (DMSO) at 35°C. Shigemi microtubes were used for the measurement of small quantities of the metabolite solution (150 ll). As an internal standard the signal of the solvent was used (DMSO: d ¼ 2.50 for 1 H). Chemical shifts (d, ppm) and coupling constants (Hz) were obtained by first order analysis. COSY spectrum was measured in absolute value mode using standard two-pulse sequence. NOESY spectra with mixing time of 0.3 s were taken as phase sensitive with standard three-pulse sequence. Assignment of signals is based on data in Stiborová et al. (2004) . All two-dimensional experiments were measured in spectral windows 5000 Hz for proton resonances (Stiborová et al., 2007) .
Modeling of ribonuclease B with oligosaccharides. Oligosaccharides (Man 5 GlcNAc 2 and GlcNAc) were built in YASARA (Krieger et al., 2004) . Force-field parameters were assigned using the AutoSMILES approach; in a first step, YASARA calculated semi-empirical AM1 Mulliken point charges that were corrected by assignment of AM1BCC atom types and improved
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Downloaded from https://academic.oup.com/toxsci/article-abstract/117/2/359/1641125 by guest on 27 March 2019 AM1BCC charges by fragments of molecules with known RESP charges, to closer resemble RESP charges. Corresponding bond, angle, and torsion potential parameters were taken from the general AMBER force field. Thereafter, three models of bovine pancreatic ribonucleases were constructed. Ribonuclease A (nonglycosylated form) was based on its crystal structure (PDB ID: 3JW1). Models of ribonuclease B and its enzymatically deglycosylated form (see the text) were based on the same protein structure, but the sugar moieties, Man 5 GlcNAc 2 or GlcNAc, were sterically fitted and covalently attached at the Asn34 in these models, respectively. Energy minimization were done by force field YAMBER3 (Krieger et al., 2004) with default parameters in explicit aqueous solution. Interestingly, the position of Man 5 GlcNAc 2 in our ribonuclease B model was in good agreement with NMR experiments (Joao and Dwek, 1993) .
Statistical analysis. Correlation coefficients were determined by linear regression using Statistical Analysis System software version 6.12. All of the p values are two tailed and considered significant at the 0.01 level.
RESULTS

Modification of (Glyco)proteins by Free Radicals Formed During HRP-Mediated Oxidation of Sudan I and Ellipticine
To evaluate the hypothesis suggesting a protective role of carbohydrate moieties in proteins against modifications of their polypeptide chains by free radicals, we performed in vitro HRP-catalyzed oxidation of Sudan I and ellipticine in the presence of proteins, such as HSA, BSA, or ribonuclease A, and a panel of various model glycoproteins with well-defined carbohydrate content (Fig. 2) .
The (glyco)proteins, HSA, BSA, ribonuclease A, ovalbumin, asialofetuin, glucoamylase, fetuin, ovomucoid, Tamm-Horsfall glycoprotein (uromodulin), and a 1 -acid glycoprotein (orosomucoid), which were utilized in the experiments (Fig. 2) , were extensively purified to homogeneity, and their oligosaccharide content was determined by MALDI-TOF MS (Bezouška et al., 1999) .
The MALDI-TOF MS spectra confirmed the reported carbohydrate content of the individual (glyco)proteins with the following percentage (wt:wt) (theoretical/experimental): ribonuclease A, 0/0; HSA, 0/0.3; BSA, 0/0.4; ovalbumin, 4.6/3.4; asialofetuin, 16.1/16.0; glucoamylase, 19.2/17.9; fetuin, 22.6/ 22.4; ovomucoid, 25.0/24.9; Tamm-Horsfall glycoprotein, 27.0/ 25.8; and a 1 -acid glycoprotein, 45.0/34.9 (Table 1) .
Our results show that free radicals generated from both Sudan I and ellipticine easily attacked the unglycosylated proteins or proteins with a low degree of glycosylation such as serum albumins, ribonuclease A, and ovalbumin (Figs. 2A and 2B), whereas much lower binding occurred to the highly glycosylated proteins ovomucoid, Tamm-Horsfall glycoprotein, and a 1 -acid glycoprotein. There was a significant inverse correlation between the amount of Sudan I or ellipticine (glyco)protein adducts and the extent of glycosylation of the proteins with correlation coefficients of 0.95 (p < 0.0003, n ¼ 8) and 0.90 (p < 0.0009, n ¼ 9) for Sudan I and ellipticine, respectively, (Figs. 2A and 2B, Tables 1 and 2 ).
The amounts of ellipticine or Sudan I metabolites formed in the peroxidase-mediated reactions were estimated after their separation from the parent compounds by HPLC (Fig. 3) , and their identity was confirmed by ESI mass spectrometry and NMR (Dračínský et al., 2009; Stiborová et al., 2007) . The predominant Sudan I metabolite (see the major product peak in Fig. 3A ) is a Sudan I dimer (Dračínský et al., 2009) (Fig. 1) . The minor oxidation product (see the minor HPLC peak in Fig. 3A) consists of 4-oxo-Sudan I skeleton connected via oxygen of its 2-hydroxyl group and nitrogen of its azo group with carbon 1 of 2-oxonaphthalene ( Fig. 1) (Dračínský et al., 2009) . The ellipticine metabolite is the ellipticine dimer (Fig. 1,  Fig. 3B ). In the presence of nucleophiles such as DNA (Stiborová et al., 1990 (Stiborová et al., , 1996 (Stiborová et al., , 2007 or protein (Fig. 2) in the reaction mixtures used for ellipticine and Sudan I oxidation by peroxidase, the levels of the dimer metabolites of these compounds (determined by HPLC, see Fig. 3 ) decreased significantly (see Fig. 4 for HSA). This finding indicates that generation of these metabolites competes with binding of reactive Sudan I or ellipticine intermediates ( Fig. 1 ) to nucleophilic centers of proteins or nucleic acids, thereby forming adducts. Indeed, the addition of HSA (0.1-1.5 mg) to the incubations resulted in formation of Sudan I-and ellipticine-HSA adducts that paralleled the decreasing yield in dimer of Sudan I (r ¼ 0.88, p < 0.05, n ¼ 5) and that of ellipticine (r ¼ 0.98, p < 0.001, n ¼ 6) (Fig. 4) .
Free radicals are responsible for the protein binding because physiological electron donors such as NADH, glutathione, and L-ascorbic acid, which are known to be effective radical scavengers (Stiborová et al., 1990 (Stiborová et al., , 1992 (Stiborová et al., , 1999 (Stiborová et al., , 2002b , decreased the levels of adducts (exemplified for the ellipticine-HSA adducts) (Table 3 ). It has already been found (Stiborová et al., 1990 (Stiborová et al., , 2002b ) that none of these scavengers is a substrate of HRP under the conditions used in this work. Thus, the scavengers do not act as competitors with ellipticine for binding to the active centre of the enzyme. The effect of scavengers is therefore based on reduction of the free radicals formed from ellipticine back to the parent compound.
Protecting Carbohydrates Must Be Covalently Bound to the Polypeptide Chain
To further clarify the mechanism leading to our observations, we decided to elucidate if the protective effects of carbohydrates are because of their chemical nature or of the sterical shielding of the protein surface. Free carbohydrates, such as glucose, sucrose, and maltose, or polysaccharide amylose, had no protective effects if present in the assay (data not shown). Likewise, the results found with deglycosylated ribonuclease B (see below) support the suggestion that protecting carbohydrates have to be covalently bound to the polypeptide chain. When this glycoprotein was deglycosylated with endoglycosidase H, the released oligosaccharides were still present in the incubation mixture, but they did not protect 362 MARTÍNEK ET AL. deglycosylated ribonuclease B against the radical modification (Fig. 2C) . The low reactivity of free radicals with carbohydrates is evident from data with amylose ( Fig. 2) excluding their function as radical scavengers, as opposed to the effects of NADH and ascorbate. As shown in Figure 4 , the Sudan I and ellipticine radicals not bound to the proteins present are quenched in the competing reactions forming dimers. A very good positive correlation was found between the degree of protein glycosylation and ellipticine dimer formed (Fig. 5) , with a correlation coefficient of 0.94 (p < 0.0002, n ¼ 9), and a significant inverse correlation was detected between the levels of ellipticine-(glyco)protein adducts and formation of the ellipticine dimer, with a correlation coefficient of 0.96 (p < 0.00004, n ¼ 9) (Fig. 5) .
Modification of Native Ribonuclease B, Deglycosylated Ribonuclease B, and Ribonucleoase A by Free Radicals Formed During Oxidation of Ellipticine by HRP Because free radicals may react with several amino acids in the polypeptide chain (cf., Liebler, 2008; Niemelä, 2001; Phillips, 2002) , we had to exclude the possible contribution of factors like amino acid composition, isoelectric point, and hydrophobic and hydrophilic surfaces of the tested (glyco)proteins. Neither the amino acid composition, the number of amino acids, their basicity and acidity, aliphatic index, their hydrophobicity/hydrophilicity (grand average of hydropathicity) (http://expasy.org/tools/protpar-ref.html), the size, nor the calculated pI correlated to the amount of Sudan I or ellipticine radicals bound to the (glyco)proteins (Tables 1   TABLE 2 Correlation Coefficients (r) between the Levels of (Glyco) Data follow from incidental cross-correlation between ''saccharide content'' and ''glycine content'' in (glyco)proteins used in the experiments, which is stronger (r ¼ 0.92, n ¼ 11, p ¼ 0.00005) than the correlation between the levels of ellipticine binding and contents of glycine (see the number in the table). **p < 0.005; ***p < 0.001.
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and 2). Thus, only the degree of glycosylation correlated well with adduct levels. To further narrow down these computational results, we performed experiments with a pair of proteins with identical polypeptide chains differing only by the absence (ribonuclease A) or presence (ribonuclease B) of a single oligosaccharide chain. Ribonuclease A was separated from ribonuclease B on immobilized Concanavalin A. Three different forms of this (glyco)protein were tested: ribonuclease A devoid of any covalently bound carbohydrates, ribonuclease B that contains about 9% carbohydrates, and ribonuclease B treated with endoglycosidase H (1.5% carbohydrates) (Fig. 6 ). This glycosidase cleaves the oligosaccharide chain after the N-acetyl-D-glucosamine residue linked to the protein, leaving the polypeptide structure essentially unaltered (Bařinka et al., 2004; Rao et al., 1995; Tarelli et al., 2000) . The purity of the isolated ribonuclease A and B preparations and the completeness of the enzymatic deglycosylation were verified by polyacrylamide gel electrophoresis (Fig. 6A ) and by MALDI-TOF MS (Figs. 6B and 6C ). The theoretical and measured values for carbohydrate content were for ribonuclease A (0/0), ribonuclease B (9.8/8.2), and deglycosylated ribonuclease B (1.5/1.5). Although both ribonuclease A and enzymatically deglycosylated ribonuclease B were highly susceptible to modifications by free radicals, the relatively low amount of covalently bound sugars in ribonuclease B already exerted a significant protective effect (Fig. 2C) .
Protection of Protein Moieties Provided by Glycan Chains Does Not Depend on Their Sugar Components
The experimental results presented in the preceding paragraphs strongly indicate that the carbohydrate chains attached to polypeptides provide a passive protection against the attack of free radicals that is proportional to the total protein glycosylation level. We next addressed the question if this protection was related to the presence of any particular carbohydrate residue. As shown below, this protection does not seem to depend on individual sugar residue. For instance, fetuin that is quite rich in sialic acids is more efficiently modified by ellipticine and Sudan I radicals than ovomucoid that is devoid of this particular carbohydrate (Table 4 and Fig. 2 ). This finding is in line with results we found using the correlation analysis.
Significant correlations were observed between the content of N-acetyl-glucosamine or mannose (Table 5) , the degree of (glyco)protein modification by ellipticine and Sudan I radicals, and also between the content of galactose and protein modification by ellipticine (Table 5 and Supplementary fig. S1 ). In contrast, no correlation was observed between the content of any of the other sugar residues and glycoprotein modification (Table 5 and Supplementary fig. S1 ). Hence, the significant correlations were found only with such saccharide components that represent a major portion of the total carbohydrate content levels that are located close to the protein surface. This indicates that levels of carbohydrates rather than their properties dictate 
GLYCOSYLATION PROTECTS PROTEINS AGAINST FREE RADICALS
the degree of glycoprotein protection against radicals. Indeed, the contents of monosaccharides that represent a major portion of the total carbohydrate building blocks (N-acetyl-glucosamine, mannose, and galactose) significantly cross-correlated with the predicted total protein glycosylation levels and with each other (Table 6 and Supplementary fig. S2 ). All these data suggest strongly that the protection, which carbohydrates provide to the protein moieties in glycoproteins, seems not to be linked to any particular sugar residue and is rather linked to the total degree of protein glycosylation.
When we correlated the degree of protein glycosylation expressed as moles of carbohydrate per mole protein, the correlation was worse compared with one in which it was expressed as percentage of the total weight (cf., Table 5 and Supplementary fig. S2 ). This can be easily understood because the protection of a small protein such as ribonuclease B (Table 4) by a single N-linked glycan chain (Fig. 6D) is obviously better than the protection of much larger ovalbumin bearing very similar glycan.
Altogether, the percentage (wt/wt) of carbohydrate contents that can be readily obtained using a relatively simple chemical analysis of glycoprotein composition may represent an easily available yet highly indicative parameter suitable for the estimation of the degree of protection of new glycoproteins not tested here.
DISCUSSION
The results of this study clearly demonstrate that carbohydrate moieties in proteins can protect their polypeptide chains against modification with free radicals formed by peroxidasemediated oxidations of the carcinogen Sudan I and the anticancer agent ellipticine. Glycosylation is one of the most common and abundant posttranslational modifications that greatly influences the properties of proteins. Today we know that there is no single unifying function for carbohydrates present in glycoproteins. Glycan chains change the physicochemical properties of glycoproteins and play a wide variety of roles in their biological functions. They modify solubility, electrical charge, mass, size, and viscosity of proteins in solution, facilitate protein folding, stabilize protein conformation, confer thermal stability and protection against proteolysis, regulate intracellular trafficking and localization of glycoproteins, determine their lifetime in circulation, modify immunological properties, modulate activity of enzymes and hormones, act as cell surface receptors for several compounds such as lectins, antibodies, and toxins, participate in cell-cell interactions, and can also perform other, more specialized functions (Bezouška, 2002 (Bezouška, , 2004 Lis and Sharon, 1993; Varki, 1993 Varki, , 2008 . Defects in glycosylation can be lethal in experimental animals, and severe disorders are observed in patients with congenital defects in glycosylation, showing the importance of glycosylation for proper development of eukaryotic organisms (Varki, 1993) . Here, we extend this list of functions of protein glycosylation, showing its additional role.
Nonglycosylated proteins such as HSA, BSA, and ribonuclease A or proteins with a low degree of glycosylation are easily modified by both compounds activated with HRP. The degree of glycosylation of a glycoprotein correlated with a Sudan I and ellipticine binding to their polypeptide chains. Amino acid composition, isoelectric point, and hydrophobic or hydrophilic nature of the tested (glyco)proteins had no effect on their modification by these radicals. The protection, which carbohydrates provide to the protein moieties in glycoproteins, seems not to be linked to any particular sugar residue, it is not dependent on charged saccharides, but is rather linked to the total degree of protein glycosylation. Using ribonucleases with identical polypeptide chains differing only by a single oligosaccharide chain or one N-acetyl-D-glucosamine residue in their molecules, we have shown that the amount of activated ellipticine bound depends only on the degree of glycosylation. In addition, the results found in this study demonstrate that the carbohydrates protect proteins against the attack by these radicals only if they are covalently attached to the proteins to provide the appropriate shielding. Therefore, our data imply that impaired protein glycosylation should result in the generation of proteins damaged by free radicals. The protective effect of glycosylation may be because of lowering the affinity of the Sudan I-and ellipticine-derived radicals and their parent molecules for the protein and thus decreases the amount of adduct produced, but this hypothesis requires further evaluation. In the absence of proteins, free radicals of both compounds generate dimers as the major metabolites of each xenobiotic employed in this study (Fig. 1) . In the presence of (glyco)proteins, the radicals not bound to the tested protein are quenched in competing reactions analogous to reactions in absence of proteins (i.e., forming dimers). Taking the structures of the ellipticine and Sudan I dimers into account, the unpaired electron of the primary ellipticine radical should be located on the secondary nitrogen atom of the pyrrole ring (N 6 ) (Stiborová et al., 2007) , whereas the primary Sudan I radical should be an oxygen-centered radical (naphthoxyl radical) (Dračínský et al., 2009) . However, even though the covalent binding of free radicals of these compounds to unglycosylated proteins such as HSA, BSA, and ribonuclease A was clearly identified, we yet know neither the exact structure of species bound to the proteins nor the amino acids that are modified.
Because the protective role of glycan chains against modification by xenobiotic radicals seems to have an important physiological significance, this property could also protect glycosylated proteins against other free radicals and electrophiles, including reactive oxygen species (ROS). The biotransformation of a vast number of structurally diverse foreign compounds, such as drugs, food additives, carcinogens, and environmental pollutants, leads to reactive electrophiles such as free radicals or carbenium and nitrenium ions, which form adducts with DNA but also with proteins. ROS produced during the activation of not only exogenous but also endogenous compounds form 8-hydroxy-2'-deoxyguanosine (Imaoka et al., 2004) . Whereas the physiological consequences of formation of DNA adducts and oxidative DNA damage are mutations implicated in carcinogenesis, those of protein adducts await further investigation (Imaoka et al., 2004; Phillips, 2002) . Enzymes metabolizing xenobiotics, which are thereby exposed to reactive electrophilic species including radicals, have been shown to be modified in the catalytic process (Beaune et al., 1994; Bořek-Dohalská et al., 2001; Giraud et al., 1992; Mareeva et al., 1996; Perera, 1995; Silva et al., 1990; Uetrecht, 1997) . In most incidences, these events lead to the inactivation of the enzymes (Bořek-Dohalská et al., 2001; Giraud et al., 1992; Mareeva et al., 1996; Rauniyar et al., 2009; Silva et al., 1990) . Thus, the well-known fact that proteins are N-glycosylated cotranslationally immediately upon their entrance into the endoplasmic reticulum, where they can meet the free radicals discussed above, is worth mentioning (Chavan and Lennarz, 2006; Yan and Lennarz, 1999) . Moreover, the results found in this work might have importance in enzyme biotechnology. Namely, based on findings published here, high glycosylation of enzymes employed in enzyme technology should increase their resistance against the attack by free radicals and prolong their half-life, especially in an oxidative environment (Jacobs and Callewaert, 2009 ). In addition, modifications of proteins by radicals and/or other electrophilic species including ROS have been implicated in the proapoptotic events connecting inflammation to the development of several diseases (Chen et al., Cohen et al., 2009; Lytton et al., 1999; Stadler et al., 2008) . The occurrence of hypoglycosylated proteins damaged by oxidative stress is now indeed observed in a growing number of diseases such as asthma, vascular injuries, heart attack, kidney failure, and the neurodegenerative disorders (Kurup and Kurup, 2003; Mao et al., 2005; Naruszewicz et al., 2009; Wang et al., 2002) . The recent complex proteomic analysis of serum from patients with congenital disorder of glycosylation Ia, in which the pathway of N-glycosylation is damaged because of a genetic defect, compared with serum from normal healthy subjects has found that these patients produce increased concentrations of proteins involved in immune response, blood coagulation, and tissue protection against oxidative stress (Richard et al., 2009) . This may be a mechanism by which these patients compensate the genetic defect leading to increased tissue damage as a result of the missing protective glycoprotein glycans. In general, the degree of the actual damage of proteins by radicals may vary considerably as a function of the severity of the oxidative stress as well as amino acid composition and sequence of a particular protein (Davies and Dean, 1997; Maleknia and Downard, 2001; Nakamura and Stadtman, 1984) . In view of these findings, one may envisage that protein glycosylation may have evolved in order to protect the proteins that are particularly sensitive to damage by radicals, whereas some other proteins that are inherently insensitive to this process (Nakamura and Stadtman, 1984) may not actually need such a protection. Moreover, although some proteins may be efficiently protected by radical scavengers present in the endoplasmic reticulum during their biosynthesis, for some very sensitive (glyco)proteins that are not fully protected by these scavengers, glycosylation of their polypeptide chains may represent an additional necessary level of protection.
The susceptibility of a particular protein to free radicalmediated damage may be less physiologically relevant if the protein undergoes rapid turnover or if it is synthesized in large amounts. Data found by several authors (Bredow and Goldie, 1985; Margen and Tarver, 1956; Van Lenten and Ashwell, 1971) suggest that there is obviously no significant contribution of protein glycosylation to their turnover rate (half-life). The nonglycosylated protein HSA has the half-life of 26.5 days (Margen and Tarver, 1956) , whereas in the same environment (in blood plasma), the highly glycosylated a 1 -acid glycoprotein (orosomucoid) elicits much shorter half-life, 22 h (Van Lenten and Ashwell, 1971) . The half-life of medium glycosylated fetuin is reported to be 3.5 days (Bredow and Goldie, 1985) . Therefore, the turnover rates of individual (glyco)proteins are determined predominantly by specific mechanisms of their degradation rather than their susceptibility to covalent modification (i.e., protein adduct formation). The susceptibility of proteins to damage in vivo may be dependent on several factors such as prevalence and location in the body, the presence of free radical detoxification mechanisms in different tissues, etc. Hence, although the protection of proteins by glycosylation is an interesting phenomenon found in vitro, its in vivo relevance needs further investigation. Another feature that awaits further examination is the toxicological impact of covalent binding of radicals to proteins. The impact of the random covalent binding of other reactive metabolites derived from drugs to proteins has been studied in several recent publications (Bauman et al., 2009; Leone et al., 2007; Obach et al., 2008) . These studies have pointed out the difficulty in making correlations about the level of binding and any measurable toxicology signals (Bauman et al., 2009; Obach et al., 2008) . The random binding found in the present study is rather similar and would also be difficult to translate it into toxicologically meaningful endpoints.
In conclusion, the results of the present study show for the first time that glycan chains protect polypeptides against binding of free radicals formed enzymatically from xenobiotics and suggest this process to be a novel role of sugar chains in glycoproteins. This finding is a result that might open a new field of research in glycosciences because nothing at all is known about the mechanism of such protection of proteins by oligosaccharides. Further research will have to show whether this finding is of general importance also for radicals of other xenobiotics and for those such as ROS formed from endogenous substrates. Likewise, we feel that investigations of the physiological relevance of glycosylation for the protection of proteins in oxidative environments and in environments, in which xenobiotics are metabolized, might be one of the major challenges in toxicology and glycobiology research. 
